BNTC

Conviction 73HealthcareScan · Mon, Aug 10, 2026

BNTC$13.74+0.81%

ResistanceSupportVol 14

Vol MA14 89.61K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Benitec Biopharma Inc.PHARMACEUTICAL PREPARATIONSwww.benitec.com ↗

Price13.74

Change+0.81%

Gap+1.72%

Rel volume2.13×

Avg volume82.38K

Avg $ vol1.01M

SMA 2012.33

SMA 5012.16

SMA 20012.29

Price vs 50+12.98%

Price vs 200+11.82%

MA stackmixed

50/200 cross—

Supertrendup · 11.50

RSI (14)68

MACD hist0.19

MACD crossbull · 3d

Stoch %K / %D94 / 94

ADX (14)19

+DI / −DI27 / 13

RSI divergence—

MACD divergence—

ATR %+5.27%

ADR %5.56%

52w high16.52

52w low10.06

From 52w high-16.83%

Above 52w low+36.58%

New 52w highNo

SqueezeOff

Bollinger width22.72%

%B1.00

Donchian pos93.78%

Donchian high13.92

Donchian low11.10

AVWAP (52w high)12.26

vs AVWAP high+12.10%

AVWAP (52w low)11.80

vs AVWAP low+16.40%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d2.13×

Avg vol (14d)89.61K

Avg vol (20d)82.38K

Avg $ vol (20d)1.01M

Market cap—

RS 3m (vs SPY)+6.58%

RS 6m (vs SPY)+2.88%

RS line new highNo

Trend template5/8

Technical rank79.8

1 week+13.09%

1 month+2.38%

3 months+11.89%

6 months+13.37%

1 year+16.94%

YTD+9.18%

P/E-12.35

P/B2.55

P/S—

P/FCF-19.84

EPS-1.05

Div yield—

ROE-20.68%

ROA-20.28%

Debt/Eq—

Current56.82

EV/EBITDA-6.80

Gross margin—

Net margin—

Rev growth-42.16%

EPS growth-74.32%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value283.49M

Revenue0

Net income-11.94M

Gross profit—

Free cash flow-23.61M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out34.35M

Employees19

ListedWed, Jul 11, 2012

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction73 / 100

Pattern quality—

Tech rank79.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance14.09

Support10.98

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BNTC

All disclosures →

No recent disclosed trades by Congress in BNTC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BNTC · 1 buy · 1 sell

Insider	Side	Shares	Value	Traded	Filed
BUCHI J KEVIN Director · Common Stock · 2026-06-29	Gift	51.81K	—	2026-06-29	2026-06-30
Friedman David Matthew Director · Options (right to buy) · 2026-05-26	Grant	35K	$0	2026-05-26	2026-05-28

SEC filings

EDGAR filings in BNTC

EDGAR →

No recent SEC filings on file for BNTC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.